Want to see SE:MYCR full AI Analyst Report?
Top Page
Mycronic AB
(MYCR)
Select Model
Select Model
Rating:67Neutral
Price Target:
kr327.00
▼(-1.57% Downside)
Action:Reiterated
Date:10/23/26
The score is driven primarily by strong fundamentals—high margins, strong multi-year growth, and an exceptionally low-debt balance sheet—tempered by weaker cash-flow conversion and volatility. Technicals materially detract as the stock is in a pronounced downtrend with negative momentum. Valuation is also a moderate headwind given the elevated P/E and modest dividend yield.
Positive Factors
Premium profitability
Mycronic’s strong gross, operating, and net margins indicate valuable technology, pricing power, and disciplined execution. Sustained profitability should support internal funding for research, product development, and customer support while providing resilience through normal industrial demand fluctuations.
Negative Factors
Weak cash conversion
The gap between reported earnings and cash generation reduces visibility into how efficiently profits become deployable funds. If this pattern persists, working-capital or investment demands could constrain internally funded growth and make cash available for shareholder returns or strategic investment less predictable.
Read all positive and negative factors
Positive Factors
Negative Factors
Premium profitability
Mycronic’s strong gross, operating, and net margins indicate valuable technology, pricing power, and disciplined execution. Sustained profitability should support internal funding for research, product development, and customer support while providing resilience through normal industrial demand fluctuations.
Read all positive factors
Mycronic AB (MYCR) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr61.18B
Dividend Yield1.04%
Average Volume (3M)307.87K
Price to Earnings (P/E)30.7
Beta (1Y)0.83
Revenue Growth16.55%
EPS Growth14.12%
CountrySE
Employees2,772
SectorGeneral
Sector StrengthN/A
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)10.19
Shares Outstanding195,833,020
10 Day Avg. Volume434,703
30 Day Avg. Volume307,867
Financial Highlights & Ratios
PEG Ratio-3.77
Price to Book (P/B)6.13
Price to Sales (P/S)5.49
P/FCF Ratio33.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)11.13
Revenue Forecast (FY)kr9.77B
Mycronic AB Business Overview & Revenue Model
Company Description
Mycronic AB (publ), based in Täby, Sweden, is a global entity dedicated to the creation, production, and sale of advanced manufacturing machinery for the electronics sector. The company operates extensively across Sweden, wider Europe, North and S...
How the Company Makes Money
Mycronic makes money primarily by selling high-value capital equipment used in electronics manufacturing and by generating recurring revenue from supporting that installed base. Key revenue streams typically include: (1) System/equipment sales: on...
Mycronic AB Financial Statement Overview
Summary
Income Statement
88
Very Positive
Balance Sheet
92
Very Positive
Cash Flow
74
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.30B | 7.94B | 7.06B | 5.71B | 5.12B | 4.63B |
| Gross Profit | 5.00B | 4.12B | 3.72B | 2.72B | 2.29B | 2.28B |
| EBITDA | 3.06B | 2.30B | 2.37B | 1.51B | 1.16B | 1.26B |
| Net Income | 1.99B | 1.56B | 1.68B | 998.00M | 741.00M | 828.00M |
Balance Sheet | ||||||
| Total Assets | 13.24B | 10.92B | 10.41B | 8.34B | 7.34B | 6.14B |
| Cash, Cash Equivalents and Short-Term Investments | 3.27B | 2.32B | 3.01B | 2.14B | 1.27B | 683.00M |
| Total Debt | 415.00M | 348.00M | 219.00M | 228.00M | 270.00M | 243.00M |
| Total Liabilities | 4.74B | 3.81B | 3.84B | 3.06B | 2.64B | 2.14B |
| Stockholders Equity | 8.50B | 7.11B | 6.53B | 5.25B | 4.66B | 3.96B |
Cash Flow | ||||||
| Free Cash Flow | 999.00M | 1.32B | 1.64B | 1.41B | 712.00M | 908.00M |
| Operating Cash Flow | 2.41B | 1.41B | 1.87B | 1.61B | 853.00M | 998.00M |
| Investing Cash Flow | -462.00M | -1.13B | -500.00M | -195.00M | 67.00M | -1.22B |
| Financing Cash Flow | -818.00M | -862.00M | -552.00M | -447.00M | -382.00M | -437.00M |
Mycronic AB Technical Analysis
Positive
332.20
Price Trends
322.75
Negative
320.32
Negative
280.21
Positive
Market Momentum
-7.42
Positive
47.06
Neutral
76.42
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:MYCR, the sentiment is Positive. The current price of 332.2 is above the 20-day moving average (MA) of 320.88, above the 50-day MA of 322.75, and above the 200-day MA of 280.21, indicating a neutral trend. The MACD of -7.42 indicates Positive momentum. The RSI at 47.06 is Neutral, neither overbought nor oversold. The STOCH value of 76.42 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:MYCR.
Mycronic AB Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | kr879.19B | 33.22 | 24.21% | 1.83% | 2.72% | 0.11% | |
67 Neutral | kr61.18B | 30.66 | 25.38% | 1.04% | 16.55% | 14.12% | |
67 Neutral | kr227.33B | 27.93 | 17.58% | 1.64% | 4.27% | -2.41% | |
65 Neutral | kr456.72B | 23.94 | 18.92% | 1.65% | 14.34% | 29.04% | |
61 Neutral | kr4.82B | 21.50 | ― | 2.91% | -6.05% | -24.08% | |
60 Neutral | kr25.94B | 48.86 | 10.12% | 1.13% | -0.19% | 78.46% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
SE:MYCR
Mycronic AB
312.40
90.69
40.90%
SE:ALFA
Alfa Laval AB
550.00
103.46
23.17%
SE:ATCO.B
Atlas Copco AB
164.20
25.72
18.57%
SE:SAND
Sandvik AB
364.10
80.11
28.21%
SE:MTRS
Munters Group AB
142.00
-18.58
-11.57%
SE:NMAN
Nederman Holding AB
137.40
-18.68
-11.97%
Mycronic AB Corporate Events
Mycronic Lifts 2026 Sales Outlook as Global Technologies Drives Earnings Surge
Oct 22, 2026
Mycronic AB reported a robust third quarter, with order intake up 10 percent to SEK 2,667 million and net sales jumping 38 percent to SEK 2,356 million, driven mainly by strong performance in Global Technologies across all divisions. EBIT more tha...
Mycronic Names Mikael Wahlsten to Lead Pattern Generators Division
Oct 21, 2026
Mycronic AB has appointed longtime executive Mikael Wahlsten as Senior Vice President Pattern Generators and member of the executive management team, effective November 1, 2026, succeeding Charlott Samuelsson, who is retiring after three decades w...
Mycronic Wins SLX Mask Writer Order to Support European Chip Modernization
Oct 20, 2026
Mycronic AB has received an order worth between USD 5 million and USD 7 million from an existing customer for its SLX laser mask writer, scheduled for delivery to a European site in the third quarter of 2027. The deal underscores growing demand fo...
Mycronic Wins U.S. Order for Two SLX Semiconductor Mask Writers
Oct 14, 2026
Mycronic AB has secured an order from a U.S. customer for two SLX laser mask writers, with a total value estimated between USD 14 million and USD 16 million and delivery scheduled for the first quarter of 2028. The SLX systems, which share technol...
Mycronic sets date for Q3 2026 report and investor webcast
Oct 8, 2026
Mycronic has scheduled the release of its third-quarter 2026 report for October 22, 2026, at 8:00 a.m. CEST, followed by a webcast presentation at 10:00 a.m. CEST for analysts, investors and media. The event, led by President and CEO Anders Lindqv...
Mycronic Appoints Nomination Committee for 2027 AGM
Sep 15, 2026
Mycronic AB has appointed the Nomination Committee for its 2027 Annual General Meeting in line with instructions approved at the 2026 AGM. The committee consists of representatives from major shareholders Bure Equity, SEB Funds and the Fourth Swed...
Mycronic Sets Ambitious Long-Term Growth and Profitability Targets
Aug 31, 2026
Mycronic has set new long-term financial targets, aiming to lift net sales to SEK 20 billion in the period 2032–2035 while maintaining an EBIT margin of around 25 percent. The unchanged sustainability goals and requirement that each division...
Mycronic wins USD 21–24 million Prexision 80 Evo order from Asian display customer
Aug 28, 2026
Mycronic has received a replacement order from an existing Asian customer for a Prexision 80 Evo mask writer, a high-end system designed to meet the demanding requirements of complex display photomasks. The order, valued between USD 21 million and...
Mycronic wins new Asian order for SLX semiconductor mask writer
Aug 13, 2026
Mycronic’s Pattern Generators division, which supplies mask writers and metrology systems for display and semiconductor manufacturing, has secured a new customer in Asia for its SLX laser mask writer. The order, valued between USD 4 million ...
Mycronic wins Asian order for SLX laser mask writer
Jul 23, 2026
Mycronic has secured an order valued between USD 5 million and 7 million from an existing customer in Asia for its SLX laser mask writer, with delivery scheduled for the second quarter of 2027. The SLX system, which leverages technology from Mycro...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.